
Will AI developed molecules or drugs be the dominant sources of new biopharma IP by Sep 5 2029?
5
100Ṁ1002029
74%
chance
1H
6H
1D
1W
1M
ALL
https://x.com/tszzl/status/1831824924140556633
resolves according to my wisdom
This question is managed and resolved by Manifold.
Market context
Get
1,000 to start trading!
People are also trading
Related questions
Will the markov.bio AI copilot for drug discovery be influential in the R&D of a marketed drug? (Before 2030)
8% chance
How many AI-generated drugs will be approved by the FDA by the end of 2030?
16
9. One of the large global pharma companies will acquire one of the leading protein AI startups.
60% chance
Will AI be regularly used to diagnose complex diseases by 2028?
26% chance
Will there be reports of an AI playing a significant role in biological gain-of-function research before 2030?
79% chance
The FDA will approve an AI developed cure before the end of the decade (<2030) for a previously incurable major illness.
55% chance
Will an AI be able to write a prescription for medication in the US or a EU member country by 2030?
15% chance
Will AI be able to provide an end-to-end plan for bioweapons production by 2026 EOY?
64% chance
Will biopharma VC funding in one year have exceeded $100 billion USD by 2030?
70% chance
Will AI surpass humans in conducting scientific research by 2030?
30% chance